Charles River Laboratories | Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Agilent USD 1.76B 31M 2025-12
Align Technology USD 1B 103.43M 2025-09
Bio-Rad Laboratories USD 529.8M 134M 2025-12
Bruker USD 293.1M 201.1M 2025-09
Cardinal Health USD 2.78B 1.82B 2025-12
Charles River Laboratories USD 213.77M 6.67M 2025-12
Cigna USD 7.68B 1.65B 2025-12
Concord Medical Services Hldg CNY 243.38M 85.1M 2023-06
CVS Health USD 8.45B 645M 2025-12
Danaher USD 4.62B 3.09B 2025-12
Dentsply International USD 363M 4M 2025-09
Elevance Health USD 9.49B 778M 2025-12
Galapagos EUR 64.46M 43.61M 2025-09
Hologic USD 2.17B 208.5M 2025-12
Humana USD 4.2B 1.19B 2025-12
Illumina USD 1.42B 368M 2025-12
Incyte USD 3.58B 650.78M 2025-12
Intrexon USD 9.34M 1.77M 2024-06
IQVIA Holdings USD 1.98B 166M 2025-12
Laboratory Of America USD 532.3M 65.8M 2025-12
Lonza CHF 1.11B 286M 2024-12
McKesson USD 2.96B 1.05B 2025-12
Merck EUR 1.17B 161M 2025-06
Mettler Toledo International USD 69.06M 7.24M 2025-09
Novartis USD 9.56B 2.9B 2025-09
Pfizer USD 1.34B 295M 2025-09
Quest Diagnostics USD 420M 12M 2025-12
Revvity USD 919.86M 11.53M 2025-12
Thermo Fisher Scientific USD 9.85B 7.87B 2025-12
United Therapeutics USD 1.56B 217M 2025-12
UnitedHealth USD 28.12B 2.49B 2025-12
Veradigm USD 492.6M 7.57M 2022-09
Waters USD 587.83M 128.71M 2025-12
West Pharmaceutical Services USD 791.3M 162.8M 2025-12


Charles River Laboratories Zahlungsmittel Und Äquivalente - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.